How Much Did AccuLab Life Sciences Raise?
Funding & Key Investors

AccuLab Life Sciences has secured $2.6M in total capital, with a recent strategic investment of $2.6M marking a significant milestone in its growth trajectory. This latest financing round underscores the company's pivotal role in the preclinical contract research organization (CRO) sector, particularly within the competitive San Diego biotechnology hub.

What is AccuLab Life Sciences?

AccuLab Life Sciences
Business ServicesResearch & Development

AccuLab Life Sciences operates as a preclinical Contract Research Organization (CRO) with over 35 years of specialized experience. Based in San Diego, the company focuses on providing essential development testing and clinical trial support for both small and large molecules. Their comprehensive service portfolio includes immunogenicity testing, bioanalysis for clinical trials, and rigorous testing for medical devices and combination products. AccuLab has established itself as a trusted partner for a diverse clientele, ranging from major pharmaceutical corporations to emerging biotech firms, by consistently delivering reliable and reproducible results with a strong emphasis on customer service. The organization is dedicated to translating innovative client concepts into viable solutions while maintaining strict adherence to regulatory standards.

How much funding has AccuLab Life Sciences raised?

AccuLab Life Sciences has raised a total of $2.6M across 1 funding round:

2025

Debt

$2.6M

Debt (2025): $2.6M with participation from Western Alliance Bank

Key Investors in AccuLab Life Sciences

Western Alliance Bank

Western Alliance Bank is a prominent financial institution known for providing significant debt financing solutions, supporting the operational and growth needs of companies across various sectors, including life sciences.

What's next for AccuLab Life Sciences?

The substantial enterprise-level funding and recent strategic investment signal AccuLab Life Sciences' intent to further solidify its market position and potentially expand its service offerings. This infusion of capital is likely to fuel advancements in their testing capabilities, support broader clinical trial initiatives, and enhance their capacity to serve a growing demand for high-quality preclinical research. The company's focus on reliability and regulatory compliance positions it for continued success in supporting the development pipelines of pharmaceutical and biotech innovators.

See full AccuLab Life Sciences company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesProject Management
Business ServicesProject ManagementAccounting for Legal Practices
Advertising NetworksBusiness ServicesGraphics
Advertising NetworksBusiness ServicesGraphics

Frequently Asked Questions Regarding AccuLab Life Sciences Financial Insights

What are the most recent funding rounds that AccuLab Life Sciences has completed, and what were the funding rounds?
AccuLab Life Sciences has recently completed 1 funding rounds: Debt on Mar 31, 2025.
What is the total amount of funding AccuLab Life Sciences has raised to date?
AccuLab Life Sciences has raised a total of $2.6M in funding to date.
How many funding rounds has AccuLab Life Sciences completed?
AccuLab Life Sciences has completed 1 funding rounds.
How much funding did AccuLab Life Sciences raise in its most recent funding round?
AccuLab Life Sciences raised $2.6M in its most recent funding round.
Who are the lead investors in AccuLab Life Sciences's latest funding round?
The lead investor in AccuLab Life Sciences's latest funding round was Western Alliance Bank. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in AccuLab Life Sciences's history?
The largest funding round in AccuLab Life Sciences's history was $2.6M.
See more information about AccuLab Life Sciences